Apple Eases On Bonus & Hiring, Federal Reserve Mulls Tougher Rules After SVB Failure, Meta-Backed Undersea Cable Project Delayed By China: Today’s Top Stories
Reuters
Fed Mulling Tougher Rules For Midsize Banks After SVB Crash
Silo Pharma Announces Results From IND-Enabling Study Of SP-26 For Fibromyalgia; Shares Move Higher
Silo Pharma, Inc. (NASDAQ:SILO) ("the Company"), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that it has achieved
ThermoGenesis Announces Roll Out Of ReadyStart cGMP Suites For Early-Stage Cell And Gene Therapy Companies; Shares Move Higher
ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company is rolling out a new
Roivant Announces Phase 3 Trial Of VTAMA Achieved Primary Endpoint And All Secondary Endpoints
46.4% of subjects receiving VTAMA cream, 1% achieved the primary endpoint of Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-ADTM) response of clear (0) or almost clear (1) with at
Pfizer and BioNTech On Tuesday Received U.S. Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Booster in Children Under 5 Years
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced Tuesday that the U.S.
Reported Late Tuesday March 14, Deciphera Pharmaceuticals Announces QINLOCK Included In NCCN Guidelines For The Treatment Of Second-Line GIST Patients And FDA Grants Breakthrough Therapy Designation For QINLOCK In Second-Line GIST Patients With Mutatio…
– NCCN Guidelines Include QINLOCK as a Preferred Regimen for Second-Line GIST Patients Intolerant to Sunitinib –
Data For Pfizer’s COVID-19 Drug Shows No Possible Association With Infection Rebound
The FDA dropped in briefing document as the agency’s external advisors meet on Thursday (March 16) to discuss complete approval…
Amgen Faces Lawsuit For Hiding Its Stupendous Tax Bill Of $10B
In a complaint filed in Manhattan federal court, a Detroit-based pension fund said Amgen Inc (NASDAQ:AMGN) concealed the dispute over…
Analyst Says Biogen-Eisai’s Alzheimer’s Treatment Leqembi Coverage Enables Access To Over $2.5B Market Opportunity
Eisai Co Ltd (OTC:ESALY) and Biogen Inc (NASDAQ:BIIB) said the U.S. Department of Veteran Affairs (VA) would provide coverage of their…